Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.

ABSTRACT:

Importance

Chemotherapy-induced alopecia is a common and distressing adverse effect. In previous studies of scalp cooling to prevent chemotherapy-induced alopecia, conclusions have been limited.

Objectives

To evaluate whether use of a scalp cooling system is associated with a lower amount of hair loss among women receiving specific chemotherapy regimens for early-stage breast cancer and to assess related changes in quality of life.

Design, setting, and participants

A prospective cohort study conducted at 5 US medical centers of women with stage I or II breast cancer receiving adjuvant or neoadjuvant chemotherapy regimens excluding sequential or combination anthracycline and taxane (106 patients in the scalp cooling group and 16 in the control group; 14 matched by both

SUBMITTER: Rugo HS 

PROVIDER: S-EPMC5639721 | biostudies-literature | 2017 Feb

REPOSITORIES: biostudies-literature